Imbruvica Coupons & Savings Card – Discount Prices from $16399.63
My prescription
Edit
560MG, Imbruvica (28 Tablets)
Select pharmacy
Albertsons
$16,399.63
COUPON PRICE
Walmart
$16,467.94
COUPON PRICE
Walgreens
$16,478.93
COUPON PRICEImbruvica savings card
Show this card to your pharmacistAlbertsons
$16,399.63
BIN
ID
PCN
GRP
019876
LH54A25336
CHIPPO
LHX
Powered by
Related kinase inhibitors prescriptions
More prescriptions for Hodgkin's lymphoma
Related kinase inhibitors prescriptions
More prescriptions for Hodgkin's lymphoma
Price history for Imbruvica
28 Tablets, 560MG
Average retail price for Imbruvica
Average SaveHealth price for Imbruvica
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Imbruvica dosage forms
Dosage Quantity Price from Per unit 140MG 28 Tablets $10,235.11 $365.54 280MG 28 Tablets $10,235.44 $365.55 420MG 28 Tablets $10,236.52 $365.59 560MG 28 Tablets $16,399.63 $585.70
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 140MG | 28 Tablets | $10,235.11 | $365.54 |
| 280MG | 28 Tablets | $10,235.44 | $365.55 |
| 420MG | 28 Tablets | $10,236.52 | $365.59 |
| 560MG | 28 Tablets | $16,399.63 | $585.70 |
What is IMBRUVICA prescribed for?
IMBRUVICA is prescribed for the treatment of certain types of cancers, including mantle cell lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, Waldenstrm's macroglobulinemia, and marginal zone lymphoma. It is also used for chronic graft versus host disease.
Why was ibrutinib taken off the market?
Ibrutinib has not been taken off the market. It is still available and used for the treatment of certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). However, like any medication, it is important for patients to discuss potential risks and benefits with their healthcare provider.
What cancer is ibrutinib used for?
Ibrutinib is used for the treatment of several types of cancer, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), Waldenstrm's macroglobulinemia (WM), marginal zone lymphoma (MZL), and chronic graft versus host disease (cGVHD).
What is the alternative to IMBRUVICA?
An alternative to Imbruvica (ibrutinib) may include other medications such as acalabrutinib (Calquence) or zanubrutinib (Brukinsa), which are also Bruton's tyrosine kinase (BTK) inhibitors. The choice of an alternative depends on the specific condition being treated, the patient's overall health, and how they respond to treatment. It is important for patients to discuss with their healthcare provider to determine the most appropriate alternative based on their individual medical needs.
Is ibrutinib considered chemotherapy?
Ibrutinib is not considered traditional chemotherapy. It is classified as a targeted therapy, specifically a Bruton's tyrosine kinase (BTK) inhibitor, used to treat certain types of blood cancers by interfering with specific pathways that promote cancer cell growth.